Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Postoperative HemorrhagePostoperative AnemiaPostoperative Blood Loss
Interventions
OTHER

Autologous Whole Blood Management

Intraoperative high volume autologous whole blood withdrawal with re-transfusion following weaning from CPB.

OTHER

Standard Care involving allogenic and/or derivative transfusion.

Therapeutic treatment of CPB-induced coagulopathy using donated allogenic blood products including plasma, platelets, and cryoprecipitate and/or derivative administration using prothrombin complex and fibrinogen concentrates.

Trial Locations (1)

T6G2G3

RECRUITING

University of Alberta, Edmonton

Sponsors
All Listed Sponsors
collaborator

University Hospital Foundation

OTHER

collaborator

Alberta Innovates Health Solutions

OTHER

collaborator

EPICORE Centre

UNKNOWN

lead

University of Alberta

OTHER